$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments
November 28, 2024 07:01 ET
|
Research and Markets
Dublin, Nov. 28, 2024 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering.Growth in the...
Hemophilia Markets Poised for Evolution as Competitive Dynamics between Hemlibra (Roche/Genentech) and Altuviiio (Sanofi) Intensify and Hympavzi (Pfizer) Receives Approval, According to Spherix Global Insights
October 14, 2024 12:33 ET
|
Spherix Global Insights
EXTON, PA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Hemophilia, a genetic disorder that impairs blood clotting, affects thousands of people worldwide. The treatment landscape is rapidly evolving, fueled by...
Hematology Collaboration and Licensing Deals Analysis Report and Directory 2024: Company A-Z, Headline Value, Therapeutic Area, Technology Type, Royalties
September 30, 2024 05:14 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.The report provides access to deal...
2024 Annual Eric Dostie Memorial College Scholarship Recipients
September 24, 2024 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Nufactor®, a specialty infusion company and subsidiary of FFF Enterprises, Inc. announces its 2024 Eric Dostie Memorial College Scholarship...
2024 Research Report | Hematology Analyzers and Reagents Market Anticipated to Reach USD 8.8 Billion by 2029
September 05, 2024 11:22 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price...
Global Plasma Derived Therapies Market to Surpass US$58 Billion by 2028 with Robust Growth in Immunoglobulin and Albumin Segments
June 11, 2024 09:14 ET
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Plasma Derived Therapies Market (Immunoglobulin, Hemophilia, Specialty, and Albumin): Insights & Forecast (2024-2028)" report has been added to ...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
June 10, 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024
May 02, 2024 06:30 ET
|
Aanastra Inc
Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
Comprehensive Analysis of Hematology Collaboration and Licensing Deals (2016-2024) Unveiled
May 02, 2024 05:25 ET
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Hematology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.A thorough report on hematology...
Global Cell and Gene Therapies in Hemophilia A & B Analysis Report 2024: Market to Reach $2.2 Billion by 2029 - Major Players Are Expected To Intensify Competition
April 26, 2024 07:22 ET
|
Research and Markets
Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapies in Hemophilia A & B" report has been added to ResearchAndMarkets.com's offering. The global hemophilia A and B CGT...